Why Corporate Travel Management, Kingsgate, Liontown, and Neuren shares are racing higher

These ASX shares are ending the week on a positive note.

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a small gain. In afternoon trade, the benchmark index is up 0.2% to 6,978.3 points.

Four ASX shares that are climbing more than most today are listed below. Here's why they are rising:

Corporate Travel Management Ltd (ASX: CTD)

The Corporate Travel Management share price is up almost 4% to $17.37. This may have been driven by a broker note out of Morgan Stanley. It has retained its overweight rating and $28.00 price target. The broker feels the market is being too negative and believes the company can achieve its guidance in FY 2023.

Kingsgate Consolidated Limited (ASX: KCN)

The Kingsgate share price has jumped 17% to $1.77. Investors have been buying this gold miner's shares after it announced the official reopening of its Chatree mine in Thailand. This follows the granting of approval from the Department of Primary Industries and Mines. Management described it as "a truly remarkable moment."

Liontown Resources Ltd (ASX: LTR)

The Liontown share price is up 4% to $1.59. This is despite there being no news out of the lithium developer. However, it is worth noting that a number of lithium shares are climbing today. Some investors may believe a buying opportunity has opened up following heavy declines in recent sessions.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is up a further 8% to $13.40. This biotech company's shares have been on fire this week thanks to news that its treatment for Rett's Syndrome has been granted US FDA approval. This is the first and only approved treatment for the rare genetic neurological and developmental disorder that affects the way the brain develops. It is expected to be available by the end of April 2023.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why 4DMedical, Regis Resources, Unico Silver, and WiseTech Global shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

A mature-aged woman wearing goggles and a red cape, rides her bike along the beach looking victorious.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough Tuesday for investors.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BlueScope, DroneShield, Monadelphous, and SGH shares are racing higher today

These shares are outperforming on Tuesday. But why?

Read more »

Man looking at digital holograms of graphs, charts, and data.
Share Gainers

Top 5 ASX 200 tech shares for growth in 2025

It was a rollercoaster year for ASX 200 tech shares, with fears of an AI bubble sending them into a bear…

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX had a lukewarm start to the week today.

Read more »

A young woman raises her arm in celebration against a backdrop of brightly coloured fireworks in the sky.
Share Gainers

Buying ASX uranium shares like Paladin Energy? Here's why they're starting 2026 with a bang!

Investors are piling into ASX uranium stocks in these early days of 2026. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Civmec, Fenix, Paladin Energy, and Vulcan Steel shares are pushing higher today

These shares are starting the week on a positive note.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why 4DMedical, Elsight, Judo, and Nickel Industries shares are pushing higher today

These shares are starting the year in a positive fashion. But why?

Read more »